Singapore is often held up as a model for efficient and high-quality healthcare. A look at the numbers and trends helps us understand where pharmaceutical partners like Taj Pharma can contribute meaningfully.
In 2025, the Singapore government has allocated S$20.9 billion toward healthcare spending.
This is second only to defense in the national budget. Projections suggest that by 2030, healthcare spending could approach S$30 billion per year as demographic pressures (particularly an ageing population) increase demand.
Government health expenditure is rising both in absolute terms and as a share of GDP.
To help families manage costs, the government increases subsidies, expands MediSave/MediShield withdrawals, and boosts support for long-term care and elder care.
Major Health Issues & Disease Burden in Singapore
Understanding what diseases are most prevalent helps tailor medicine supply, public health interventions, and patient education.
| Condition | Statistics / Trends |
|---|---|
| Hyperlipidaemia (high cholesterol / lipids) | ~ 39.1 % of adults aged 18-69 years in recent years.Ministry of Health |
| Hypertension | ~ 37 % among adults aged 18-69.Ministry of Health |
| Diabetes | Prevalence is around 8-10 % in similar adult age groups.Ministry of Health |
| Obesity | Rising: 8.6 % (earlier) to ~ 11.6 %.Ministry of Health |
| Smoking (daily smokers) | Around ~ 9-10 %. Slight fluctuations.Ministry of Health |
| Cancers | Among leading incidences: prostate (for men), breast (for women), colon & rectum for both sexes.Ministry of Health |
| Other chronic and non-communicable diseases (NCDs) such as cardiovascular, metabolic (e.g. high blood lipids, hypertension, type 2 diabetes) are increasingly dominant over infectious diseases. |
Singapore’s Medical / Pharmacy Dispensing System
While the precise list of medicines provided by a specific manufacturer (like Taj Pharma) to Singapore is not public in full detail, some general practices in Singapore are:
- Public hospitals and polyclinics provide subsidised medicines for patients, especially for chronic diseases. Patients often pay less depending on means and subsidy tiers.
- There is a national framework combining MediSave (medical savings), MediShield Life (insurance), and Medifund (a safety net fund) to ensure affordability.
- Outpatient subsidies are being expanded. For example, eligibility and amounts for MediSave withdrawal for outpatient scans and treatments are being increased.
Taj Pharma: What We Offer
Taj Pharma is well positioned to support Singapore’s health needs by providing quality medicines, innovations, and partnerships.
Product Range
Taj Pharma’s portfolio includes a wide range of therapeutic categories, including but not limited to:
- Cardiovascular
- Anti-infectives (antibiotics, antivirals)
- Central Nervous System (CNS) agents (antidepressants, antiepileptics, etc.)
- Anti-inflammatory
- Oncology (cancer medicines)
- Anti-diabetic medicines
- Analgesics / Pain management
- Dermatology, respiratory health, women’s healthcare, etc.
Manufacturing Quality & Capacity
- All manufacturing done via WHO-GMP, GLP, ISO-certified partners.
Diverse dosage forms: tablets, capsules, dry syrups, liquid injections, soft gelatin capsules, ointments/creams, external liquids, etc.
Capability to produce both human pharmaceuticals and veterinary medicines.
New / Notable Products
Some of the more recent generics & products include:
- Escitalopram, Olanzapine, Quetiapine (CNS)
- Lipid-lowering drugs such as Atorvastatin / Fenofibrate, and Rosuvastatin
- Anti-ulcer (Esomeprazole)
- Anti-obesity agents (Orlistat)
These kinds of medicines are quite relevant given Singapore’s disease burden (e.g. cardiovascular disease, obesity, metabolic disorders, mental health).
Taj Pharma’s Vision & Mission (Singapore Context)
- Vision: To provide high-quality, affordable, and innovative pharmaceutical solutions globally, including Singapore, where quality, safety, and efficacy are paramount.
- Mission: To prevent, diagnose, alleviate, and cure diseases by discovering, developing and marketing medicines that meet global standards; to ensure patient well-being through access, reliability, transparency and innovation.
How Taj Pharma Aligns With Patient Needs in Singapore
From a patient perspective, here’s how Taj Pharma helps address the needs:
- Affordability: By offering generics and competitively priced medicines, Taj Pharma can help reduce out-of-pocket costs for chronic condition management.
- Availability: Wide therapeutic categories and multiple dosage forms increase the likelihood that needed medicines are available locally.
- Quality assurance: Certifications and manufacturing transparency build trust among patients, healthcare providers, and regulators.
- Supporting national priorities: Medicines for diseases like diabetes, hypertension, obesity, mental health, etc., are among Singapore’s high disease burden; Taj Pharma’s portfolio includes such drugs.
- Partnership potential: For national medical pharmacies, bulk tendering, hospital supply, or outpatient dispensing, Taj Pharma can be a partner in ensuring supply chain reliability.
Key Contact & Support
For inquiries, bulk orders, or information about specific medicines, patients or institutions can reach Taj Pharma through:
- Email: Sales@tajpharmaindia.com | Info@tajpharma.com
- What’sApp: +91-7861865490
- Toll Free: 1800-222-825
We welcome enquiries from Singaporean hospitals, clinics, pharmacies, and patient groups to discuss how Taj Pharma can support access to essential medications.
Singapore’s healthcare system is strong and well-funded, but facing growing demand from aging, lifestyle-driven chronic illnesses. Affordable, quality medicines are a cornerstone of sustainable healthcare. Taj Pharma, with its broad product range, certified manufacturing, patient-centred focus and commitment to affordability, is well placed to contribute significantly to improving health outcomes in Singapore.









































































































